Capital Expenditures for STERIS (STE)
According to STERIS's latest reported financial statements, the company's current capital expenditures (TTM) is $349.69M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
STE
Currently viewingCapital ExpendituresSwitch metric
Latest period
$349.69M
YoY change
+2.7%
5Y CAGR
+11.5%
Peak year (2025)
$370.09M
Cumulative capital expenditures
$3.85B
CapEx history chart for STERIS (STE) from 1991 to 2025
CapEx history table for STERIS (STE) from 1991 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $370.09M | +2.7% | ||
| 2024 | $360.33M | -0.5% | ||
| 2023 | $361.97M | +25.9% | ||
| 2022 | $287.56M | +20.2% | ||
| 2021 | $239.26M | +11.5% | ||
| 2020 | $214.52M | +13.1% | ||
| 2019 | $189.72M | +14.7% | ||
| 2018 | $165.46M | -4.3% | ||
| 2017 | $172.90M | +36.8% | ||
| 2016 | $126.41M | +48.3% | ||
| 2015 | $85.25M | -1.3% | ||
| 2014 | $86.37M | -1.2% | ||
| 2013 | $87.41M | +31.1% | ||
| 2012 | $66.68M | -13.9% | ||
| 2011 | $77.44M | +75.7% | ||
| 2010 | $44.09M | +7.8% | ||
| 2009 | $40.89M | -28.2% | ||
| 2008 | $56.97M | +16.2% | ||
| 2007 | $49.02M | -4.2% | ||
| 2006 | $51.17M | -7.9% | ||
| 2005 | $55.54M | -16.7% | ||
| 2004 | $66.70M | +13.8% | ||
| 2003 | $58.59M | -10.8% | ||
| 2002 | $65.68M | +28.7% | ||
| 2001 | $51.02M | -33.9% | ||
| 2000 | $77.13M | -35.0% | ||
| 1999 | $118.70M | -28.4% | ||
| 1998 | $165.70M | +708.3% | ||
| 1997 | $20.50M | +35.8% | ||
| 1996 | $15.10M | -22.6% | ||
| 1995 | $19.50M | +622.2% | ||
| 1994 | $2.70M | +170.0% | ||
| 1993 | $1.00M | +42.9% | ||
| 1992 | $700,000 | +40.0% | ||
| 1991 | $500,000 | — |
CapEx values are taken from STERIS's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, STERIS (STE) reported capital expenditures of $370.09M – edged up 2.7% year-over-year.
Across 2020–2025 (5 years), STERIS capital expenditures produced a CAGR of +11.5% – with the latest reading among the more recent periods of the dataset.
$370.09M stands as the all-time-high annual capital expenditures, posted in 2025, against a low of $500,000 during 1991.
Among 8 Healthcare peers, STERIS (STE) ranks 9th; the peer median for capital expenditures is $3.87B.
STERIS Capital Expenditures by Year
STERIS Capital Expenditures 2025: $370.09M
STERIS capital expenditures in 2025 was $370.09M, edged up 2.7% from 2024. This figure represents the highest annual value in the available history.
STERIS Capital Expenditures 2024: $360.33M
STERIS capital expenditures in 2024 was $360.33M, edged down 0.5% below 2023.
STERIS Capital Expenditures 2023: $361.97M
STERIS capital expenditures in 2023 was $361.97M, grew 25.9% from 2022.
STERIS Capital Expenditures 2022: $287.56M
STERIS capital expenditures in 2022 was $287.56M, grew 20.2% from 2021.
STERIS Capital Expenditures 2021: $239.26M
STERIS capital expenditures in 2021 was $239.26M.
See more financial history for STERIS (STE).
Sector peers — CapEx
Companies in the same sector as STERIS, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is STERIS's capital expenditures?
- Latest reported capital expenditures for STERIS (STE) is $349.69M (period ending December 31, 2025).
How has STERIS capital expenditures changed year-over-year?
- STERIS (STE) capital expenditures changed +2.7% year-over-year on the latest annual filing.
What is the long-term growth rate of STERIS capital expenditures?
- STERIS (STE) capital expenditures compound annual growth rate is +11.5% over the most recent 5 years available.
When did STERIS capital expenditures hit its highest annual value?
- STERIS capital expenditures reached its highest annual value of $370.09M in 2025.
What was STERIS capital expenditures in 2024?
- STERIS (STE) capital expenditures in 2024 was $360.33M.
What was STERIS capital expenditures in 2025?
- STERIS (STE) capital expenditures in 2025 was $370.09M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
STE Overview
Company profile, financial tools, and key metrics
STE Revenue Counter
Earns $184.81 every second. See per minute, hour, and day.
STE Earnings Counter
Earns $22.44 per second net profit. See per minute, hour, and day.
STE Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
STE What If Invested
What if you had invested $1,000? See historical returns from any date.
STE How It Makes Money
Discover visual breakdown of $5.83B in revenue — where it comes from and where it goes.
STE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
STE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
STE Daily Price Character
Balanced · 49.9% historical win rate (green days). Streaks & record days.
STE Buybacks
0.83% TTM buyback yield. Shareholder yield & SBC comparison.
STE Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
STE Dividend Profile
Yield: 1.16%. Safety: 7/7. See full history.
STE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
STE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.